- Home
- BCLI vs FMST Comparison
BCLI vs FMST Comparison
Compare BCLI & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- FMST
- Stock Information
- Founded
- BCLI 2000
- FMST 2005
- Country
- BCLI United States
- FMST Canada
- Employees
- BCLI N/A
- FMST N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- FMST Other Metals and Minerals
- Sector
- BCLI Health Care
- FMST Basic Materials
- Exchange
- BCLI Nasdaq
- FMST Nasdaq
- Market Cap
- BCLI 7.9M
- FMST 7.1M
- IPO Year
- BCLI N/A
- FMST N/A
- Fundamental
- Price
- BCLI $1.16
- FMST $2.11
- Analyst Decision
- BCLI Strong Buy
- FMST
- Analyst Count
- BCLI 1
- FMST 0
- Target Price
- BCLI $30.00
- FMST N/A
- AVG Volume (30 Days)
- BCLI 141.4K
- FMST 444.8K
- Earning Date
- BCLI 05-15-2025
- FMST 01-01-0001
- Dividend Yield
- BCLI N/A
- FMST N/A
- EPS Growth
- BCLI N/A
- FMST N/A
- EPS
- BCLI N/A
- FMST N/A
- Revenue
- BCLI N/A
- FMST N/A
- Revenue This Year
- BCLI N/A
- FMST N/A
- Revenue Next Year
- BCLI N/A
- FMST N/A
- P/E Ratio
- BCLI N/A
- FMST N/A
- Revenue Growth
- BCLI N/A
- FMST N/A
- 52 Week Low
- BCLI $0.72
- FMST $0.55
- 52 Week High
- BCLI $10.05
- FMST $3.30
- Technical
- Relative Strength Index (RSI)
- BCLI 50.13
- FMST 82.04
- Support Level
- BCLI $1.12
- FMST $1.32
- Resistance Level
- BCLI $1.26
- FMST $1.23
- Average True Range (ATR)
- BCLI 0.14
- FMST 0.23
- MACD
- BCLI 0.02
- FMST 0.12
- Stochastic Oscillator
- BCLI 42.86
- FMST 94.81
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.